Takeda Pharmaceutical Company Limited Increase Decrease Through Acquisition Of Subsidiary
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Acquisition Of Subsidiary of JPY 39.45 billion for the 12-month period ending 2019-03-31, per its 20-F filed 2021-06-29.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughAcquisitionOfSubsidiary · last filed 2021-06-29
| Period end | Increase Decrease Through Acquisition Of Subsidiary 12 month |
|---|---|
| 2019-03-31 | 39.45B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 0.00 JPY 20-F · filed 2020-06-24 |